Neoadjuvant chemotherapy versus chemoradiation prior to esophagectomy: Impact on rate of complete pathologic response and survival in esophageal cancer patients

被引：0
|
作者：
Lockhart, Albert C.
Samson, Pamela Parker
Robinson, Cliff Grant
Bradley, Jeffrey D.
Puri, Varun
Broderick, Stephen R.
Patterson, G. Alexander
Meyers, Bryan F.
Crabtree, Traves
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.4054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4054
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Locally advanced esophageal cancer - evaluation of response with addition of neoadjuvant chemotherapy prior to chemoradiation
    Saha, S.
    Dastidar, A. Ghosh
    Gupta, S.
    Sarkar, S.
    ANNALS OF ONCOLOGY, 2016, 27 : 89 - 89
  • [32] Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer
    Wittmann, David
    Hall, William A.
    Christians, Kathleen K.
    Barnes, Chad A.
    Jariwalla, Neil R.
    Aldakkak, Mohammed
    Clarke, Callisia N.
    George, Ben
    Ritch, Paul S.
    Riese, Matthew
    Khan, Abdul H.
    Kulkarni, Naveen
    Evans, John
    Erickson, Beth A.
    Evans, Douglas B.
    Tsai, Susan
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [33] Racial Differences in Pathologic Complete Response Rate and Overall Survival Following Neoadjuvant Chemotherapy for Breast Cancer
    Livasy, Chad
    Donahue, Erin
    Neelands, Brittany
    Hadzikadic-Gusic, Lejla
    Sarantou, Terry
    Needham, Mckenzie
    Patrick, Alicia
    Heeke, Arielle
    Tan, Antoinette
    White, Richard
    CANCER RESEARCH, 2024, 84 (09)
  • [34] Prediction of Pathologic Complete Response to Neoadjuvant Chemoradiation in the Treatment of Esophageal Cancer Using Machine Learning
    Macomber, M. W.
    Samareh, A.
    Chaovalitwongse, W. A.
    Bowen, S. R.
    Patel, S. A.
    Zeng, J.
    Nyflot, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E699 - E699
  • [35] Neoadjuvant chemotherapy versus chemoradiation for esophageal cancer: no survival difference does not mean no differences
    Pimiento, Jose Mario
    Hofffe, Sarah E.
    Almhanna, Khaldoun
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1281 - S1283
  • [36] Survival and recurrence of breast cancer patients with pathologic complete response after neoadjuvant chemotherapy.
    Lee, Young Joo
    Ahn, Sei-Hyun
    Sohn, Byung Ho
    Lee, Jong Won
    Chung, Il Yong
    Ko, Beom Seok
    Kim, Hee Jeong
    Kim, Jisun
    Lee, Sae Byul
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Comment on 'Adjuvant chemotherapy in patients with rectal cancer achieving pathologic complete response after neoadjuvant chemoradiation and surgery'
    Ma, Bin
    Meng, Qingkai
    EUROPEAN JOURNAL OF CANCER, 2019, 112 : 32 - 33
  • [38] Complete response to neoadjuvant chemoradiation therapy for esophageal cancer does not confer a survival advantage
    C. R. Schmidt
    J. L. Tarpley
    J. R. Roberts
    A. S. Pearson
    M. C. Kelley
    M. Ninan
    J. D. Berlin
    A. B. Chakravarthy
    R. D. Beauchamp
    N. B. Merchant
    Annals of Surgical Oncology, 2004, 11 : S55 - S55
  • [39] Complete response to neoadjuvant chemoradiation therapy for esophageal cancer does not confer a survival advantage
    Schmidt, CR
    Tarpley, JL
    Roberts, JR
    Pearson, AS
    Kelley, MC
    Ninan, M
    Berlin, JD
    Chakravarthy, AB
    Beauchamp, RD
    Merchant, NB
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S55 - S55
  • [40] Bisphosphonates and Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
    Gregor, M. Chavez-Mac
    Brown, E. N.
    Lei, X.
    Hsu, L.
    Meric-Bernstam, F.
    Litton, J.
    Mittendorf, E. A.
    Valero, V.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    CANCER RESEARCH, 2010, 70
12345